In-stent restenosis in the mid-term period after successful coronary arteries chronic total occlusion recanalization by antegrade approach
https://doi.org/10.29235/1814-6023-2019-16-1-65-76
Abstract
The results on the in-stent restenosis in the mid-term period after successful coronary arteries chronic total occlusion (CTO) recanalization by the antegrade approach are assessed. The study included 117 patients who underwent coronary artery CTO recanalization for the period from 2009 to 2012. After 6.1 ± 0.9 months (stage К1) and 12.7 ± 1.6 months (stage К2), all patients were examined by coronary angiography, intravascular ultrasound and optical coherence tomography. During the frst half of the year after the CTO recanalization, there was a more frequent in-stent restenosis rate in the right coronary artery (in 25.6 %) as well as a predominance of focal types of restenosis (59.1 % of the total). The incidence of restenosis depending on the DES type varied over a wide range of values (from 0 to 52.4 % in the frst half of the year and from 0 to 41.2 % in the second half of the year). A signifcant increase in the incidence of restenosis was observed after the trapidil eluting stents implantation (52.4 % in the frst half of the year, 26.3 % in the second half of the year) and sirolimus eluting stents (38.9 % in the frst half, 41.2 % in the second half of the year). Our data show that different types of DES differently determine the changes in the vascular lumen during the medium term period after the successful CTO recanalization.
About the Author
V. I. StelmashokBelarus
Valeriy I. Stelmashok – Ph. D. (Med.), Assistant Professor, Head of the Laboratory
110B, R. Luxemburg Str., 220036, Minsk
References
1. Stone G., Kandzari D., Mehran R., Colombo A., Schwartz R., Bailey S. [et al.] Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation, 2005, vol. 112, no. 15, pp. 2364–2372. https://doi.org/10.1161/circulationaha.104.481283
2. DiMario C., Werner G., Sianos G., Galassi A., Büttner J., Dudek D. [et al.] European perspective in the recanalization of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. EuroIntervention, 2007, vol. 3, no. 1, pp. 30–43.
3. Wijeysundera H., Norris C., Fefer P., Galbraith P., Knudtson M., Wolff R., Wright G., Strauss B., Ko D. Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions. EuroIntervention, 2014, vol. 9, no. 10, pp. 1165–1172. https://doi.org/10.4244/eijv9i10a197
4. Sirnes P. A., Myreng Y., Mølstad P., Bonarjee V., Golf S. Improvement in left ventricular ejection fraction and wall motion after successful recanalization of chronic coronary occlusions. European Heart Journal, 1998, vol. 19, no. 2, pp. 273–281. https://doi.org/10.1053/euhj.1997.0617
5. Sianos G., Konstantinidis N., Di Mario C., Karvounis H. Theory and practical based approach to chronic total occlusions. BMC Cardiovascular Disorders, 2016, vol. 16, art. 33. https://doi.org/10.1186/s12872-016-0209-3
6. Stel’mashok V. I. Temporary trends of success rate and cardiac complication risk in chronic total occlusion recanalization by the antegrade approach. Vestsі Natsyyanal’nai akademіі navuk Belarusі. Seryya medytsynskіkh navuk = Proceedings of the National Academy of Sciences of Belarus. Medical series, 2017, no. 3, pp. 72–81 (in Russian).
7. Patel Y., Depta J., De Martini T. Complications of chronic total occlusion percutaneous coronary intervention. Interventional Cardiology, 2013, vol. 5, no. 5, pp. 567–575. https://doi.org/10.2217/ica.13.48
8. Stelmashok V. I. Cardiac complications risk during coronary artery chronic total occlusion (CTO) recanalization by antegrade approach. Kardiologiya v Belarusi = Cardiology in Belarus, 2017, no. 4, pp. 747–758 (in Russian).
9. Nikolsky E., Gruberg L., Rosenblatt E., Grenadier E., Boulos M., Bernstein Z. [et al.] Chronic total occlusion due to diffuse in-stent restenosis: is brachytherapy the solution? International Journal of Cardiovascular Interventions, 2004, vol. 6, no. 1, pp. 33–38. https://doi.org/10.1080/14628840310004892
10. Isaaz K., Mayaud N., Gerbay A., Sabry M., Richard L., Cerisier A., Lamaud M., Khamis H., Abd-Alaziz A., Da Costa A. Long-term clinical outcome and routine angiographic follow-up after successful recanalization of complex coronary true chronic total occlusion with a long stent length: a single-center experience. Journal of Invasive Cardiology, 2013, vol. 25, no. 7, pp. 323–329.
11. Azzalini L., Dautov R., Brilakis E., Ojeda S., Benincasa S., Bellini B. [et al.]. Impact of crossing strategy on mid-term outcomes following percutaneous revascularisation of coronary chronic total occlusions. EuroIntervention, 2017, vol. 13, no. 8, pp. 978–985. https://doi.org/10.4244/eij-d-16-01010
12. Werner G., Krack A., Schwarz G., Prochnau D., Betge S., Figulla H. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. Journal of the American College of Cardiology, 2004, vol. 44, no. 12, pp. 2301–2306. https://doi.org/10.1016/j.jacc.2004.09.040
13. Mehran R., Dangas G., Abizaid A., Mintz G., Lansky A., Satler L., Pichard A., Kent K., Stone G., Leon M. Angiographic patterns of in-stent restenosis: classifcation and implications for long-term outcome. Circulation, 1999, vol. 100, no. 18, pp. 1872–1878. https://doi.org/10.1161/01.cir.100.18.1872
14. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, 1995, vol. 57, no. 1, pp. 289–300.
15. Strigo N. P., Polonetskii O. L., Stelʼmashok V. I. Special aspects of biodegradable vascular scaffolds usage in patients with long coronary artery lesions. Kardiologiya v Belarusi = Cardiology in Belarus, 2014, no. 4, pp. 25–35 (in Russian).
16. Adnan Y., Noor L., Dar M., Ali U., Hafzullah M. Impact of stent length and diameter on short term clinical outcomes of drug eluting stents in patients with stable coronary artery disease. Pakistan Journal of Medical Sciences, 2017, vol. 33, no. 4, pp. 959–962. https://doi.org/10.12669/pjms.334.13068
17. Reifart N., Hauptmann K.-E., Rabe A., Enayat E., Giokoglu K. Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trial. EuroIntervention, 2010, vol. 6, no. 3, pp. 356–360. https://doi.org/10.4244/eijv6I3a59
18. Valenti R., Vergara R., Migliorini A., Parodi G., Carrabba N., Cerisano G., Dovellini E., Antoniucci D. Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion. Journal of the American College of Cardiology, 2013, vol. 61, no. 5, pp. 545–550. https://doi.org/10.1016/j.jacc.2012.10.036
19. Park H.-J., Kim H.-Y., Lee J.-M., Choi Y., Park C.-S., Kim D.-B. [et al.] Randomized comparison of the effcacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion – CAtholic Total Occlusion Study (CATOS) trial. Circulation Journal, 2012, vol. 76, no. 4, pp. 868–875. https://doi.org/10.1253/circj.cj-11-1021
20. Suttorp M., Laarman G. A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: rationale and design of the Primary Stenting of Occluded Native coronary arteries III (PRISON III) study. American Heart Journal, 2007, vol. 154, no. 3, pp. 432–435. https://doi.org/10.1016/j.ahj.2007.04.041
21. Moreno R., Garcia E., Teles R., Rumoroso J.-R., Carvalho H., Goicolea F. [et al.] Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial. Circulation: Cardiovascular Interventions, 2013, vol. 6, no. 1, pp. 21–28. https://doi.org/10.1161/circinterventions.112.000076
Review
For citations:
Stelmashok V.I. In-stent restenosis in the mid-term period after successful coronary arteries chronic total occlusion recanalization by antegrade approach. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2019;16(1):65-76. (In Russ.) https://doi.org/10.29235/1814-6023-2019-16-1-65-76